news
First patient enrolled in Parkinson’s treatment study
A trial has begun in the US for the ENT-01 therapy treatment of Parkinson’s, with the first patient enrolled.
List view / Grid view
Neurosciences
news
Betaine supplement reduces schizophrenic behaviours in mice
A new study found that betaine supplementations given to mice reduced schizophrenic behaviours, indicating a drug target.
news
Neurodegeneration enzyme identified in mouse models
A new study has found an enzyme in the brains of mice models which induces Parkinson’s, suggesting future drug target.
news
Alzheimer’s protein found, suggesting new drug target
Researchers have found a new drug target for Alzheimer’s disease after identifying a facilitating protein.
news
Improved human brain organoids to aid neurological disease research
Researchers have grown identical brain organoids for the first time, opening avenues for neurological research.
news
New drug target for depression identified
Researchers find key molecule in depression and identify new therapeutic targets.
news
Zebrafish reveal insights into Parkinson’s
The findings offer clues that could one day lead to treatments for the neurological condition...
news
New technology to produce dorsal cortical neurons using iPS
Scientists expect that it will soon be possible to treat brain diseases by restoring damaged areas in the brain by mass producing neurons using stem cells...
news
Neurofilament light chains detect Alzheimer’s damage before symptoms
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer's disease...
news
Nuclear tracers help assess new drugs for neurodegenerative diseases
New nuclear medicine tracers could help medical researchers find a cure for Alzheimer's and other neurodegenerative diseases.
whitepaper
Application note: GABAA Receptors
SB Drug Discovery shows the validation of fluorescence and automated electrophysiology assays designed to assess agonists, antagonists and allosteric modulators of these receptors, culminating in a high-throughput electrophysiology assay suited to assessing multiple GABAA receptor subtypes on a single assay plate.
news
Compounds in coffee may fight Parkinson’s
Caffeine plus another compound in coffee beans' waxy coating may protect against brain degeneration...
news
Depleting ErbB4 gene alleviates Schizophrenia symptoms in new mouse models
Restoring brain cell receptors helps restore normal behaviour...
news
MRI scans shows promise in predicting dementia
Brain changes evident in scans before memory, cognitive decline...
news
New information on the pathological mechanisms of Alzheimer’s disease
Researchers have indicated that the accumulation of pathological tau triggers a safety valve mechanism in the otherwise well-regulated cell membranes...
